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A 3.5-year-old boy, the second in order of birth of ﬁrst cousin
parents presented to the genetics clinic for counseling. The pa-
tient had normal development till the age of 2 years then he
started to have abnormal ataxic gait with frequent falls. At
the age of 2.5 years, he started to lose previously acquired cog-
nitive skills and speech and to develop convulsions. Neurolog-
ical examination showed hypotonia and increased deep tendon
reﬂexes. The patient had a sister and a paternal cousin with the
same clinical picture who both died at the age of 5 and 6 years.
MRI brain showed brain atrophy. Fundus examination
showed cherry-red spot (Fig. 1). The mother is 10 weeks preg-
nant and asks about prenatal diagnosis.
Q1: What is the most probable diagnosis?
The most probable diagnosis is Tay Sachs disease which is a
neurodegenerative disorder caused by intralysosomal storage
of the speciﬁc glycosphingolipid GM2 ganglioside. Common
clinical ﬁndings include progressive weakness and loss of mo-
tor and cognitive skills, decreased attentiveness and an in-* Address: Medical Genetics Center, 27A Baghdad Street, Korba,
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examination are generalized muscular hypotonia, ankle clonus,
hyperreﬂexia and normal-sized liver and spleen. This is fol-
lowed by signs of progressive neurodegeneration, seizures,
blindness, and spasticity. A cherry-red spot of the fovea cen-
tralis of the macula of the retina is usually found on fundus
examination [1].
Our patient has the juvenile (subacute) form. The disease
often begins between the age of 2 and 10 years by loss of pre-
viously acquired skills and speech followed by spasticity and
seizures. Loss of vision occurs much later than in the acute
infantile form of the disease, and a cherry-red spot – in con-
trary to our case – is not consistently observed. Instead, optic
atrophy and retinitis pigmentosa may be seen late in the
course. A vegetative state with decerebrate rigidity develops
by age 10–15 years, followed within few years by death, usually
from infection. In some cases, the disease pursues a particu-
larly aggressive course, culminating in death in 2–4 years [2].Q2: Are there other phenotypes of the disease?
Other phenotypes include [1]:
 Acute infantile (Tay-Sachs disease) with rapid progression
and death before age 4 years.
 Chronic and adult-onset Tay Sachs disease with long-term
survival. Affected individuals have several different pheno-
types, including progressive dystonia, spinocerebellar
degeneration, motor neuron disease with muscle weakness
and fasciculations, and/or psychosis.
 Activator deﬁcient Tay sachs disease: it is a rare infantile form
(phenotype identical to classic disease) where the enzymatic
activity of both hexosaminidase A (HEXA) and hexosamin-
idase B (HEX B) are normal, but GM2 ganglioside accumu-
lation occurs because of a deﬁcit of the intralysosomal
Figure 1 Cherry-red spot in Tay-Sachs disease. The right frame shows normal retina. The circle surrounds the macula, lateral to the
optic nerve. The left frame shows the macula of a child with Tay-Sachs disease. The cherry-red center is the normal retina of the fovea at
the center of the macula [1].
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dation of GM2 ganglioside, Fig. 2.Q3: Are there other diseases characterized by the presence of
cherry-red spot?
Cherry-red spot can be found in other neurodegenerative dis-
eases like GM1 gangliosidosis, Galactosialidosis, Metachro-
matic leukodystrophy, Niemann-Pick disease type A and
Sandhoff disease.
Q4: What is the differential diagnosis of this case?
Differential diagnosis will include other diseases with neuro-
logic regression like Krabbe’s disease, metachromatic leuko-
dystrophy, Canavan disease, infantile Gaucher disease, and
the neuronal ceroid-lipofuscinosis.Figure 2 The three-gene system required for hexosaminidase A activi
function of the activator protein is to bind the ganglioside substrate aQ5: How can you conﬁrm your diagnosis?
Diagnosis of Tay Sachs disease can be conﬁrmed by assay of
HEX A enzymatic activity. It relies upon the demonstration
of absent to near-absent HEX A enzymatic activity in the ser-
um, white blood cells, or other tissues from a symptomatic
individual in presence of normal or elevated activity of the
HEX B [3].
Q6: How can you perform population screening for Tay Sachs
disease?
HEX A enzymatic activity is the primary method of popula-
tion screening for carrier detection given its greater sensitivity
compared to targeted mutation analysis. However, in the Ash-
kenazi Jewish population, some have gone directly to targeted
mutation analysis (even though the sensitivity of this approachty and the diseases that result from defects in each of the genes. The
nd present it to the enzyme. NANA, N-acetyl neuraminic acid [2].
Table 1 Nature and frequency of some hexosaminidase a alleles in Ashkenazi Jewish and other populations [3].
Mutation Eﬀect on gene
product
Frequency in
Ashkenazi Jewish (%)
Frequency in non-
Ashkenazi (%)
Phenotype
4-bp insertion (exon
11)
Premature stop
codon
80 16–20 Tay-Sachs disease
Exon 12 splice
junction: G > C
Defective mRNA
splicing
10–15 <1 Tay-Sachs disease
Gly269Ser plus
abnormal splicing
<3% residual
activity
2–3 <1 Adult-onset
GM2gangliosidosis
Pseudodeﬁciency
alleles
20% residual
activity
<1 43 Normal
Educational corner 223is lower) because there are three mutations accounting for 99%
of mutations detected in this population. The commonest is 4-
bp insertion (exon 11) which is a premature stop codon muta-
tion with a frequency reaching 80% in Ashkenazi jewish pop-
ulation and 15–20% in other populations, Table 1 [3].
An unexpected consequence of screening of Tay-Sachs car-
riers in the Ashkenazi Jewish population was the discovery of
the pseudodeﬁciency alleles in which carriers of these allells
have a low hexosaminidase A activity (20% of normal) with
normal phenotypes. The importance of these alleles is that they
complicate prenatal diagnosis because a psuedodeﬁciency fetus
may incorrectly be diagnosed as affected. In this situation,
molecular diagnosis has to be done [1].
Q7: The main concern of the parents in this case was prenatal
diagnosis. How can you offer this?
Prenatal diagnosis can be offered by:
1. Enzymatic assay: by measurement of HEX A activity of
fetal cells obtained by chorionic villus sampling (CVS) at
about 10–12 weeks’ gestation or by amniocentesis at about
15–18 weeks’ gestation. But both parents have to do
enzyme level ﬁrst to rule out pseudodeﬁciency.
2. Molecular analysis (mutation analysis) of the HEXA gene
in fetal DNA extracted from cells obtained by CVS or
amniocentesis only if the disease-causing mutations have
been identiﬁed in the affected patient in the family. Molec-
ular analysis will be the only method for prenatal diagnosis
if a pseudodeﬁciency allele was detected in either parent.
Q8: What is the management of this case?
Management of such patients is supportive and directed to
provide adequate nutrition and hydration, to manage infec-
tious disease, to protect the airway, and to control seizures.
For patients who become debilitated and disabled, measures
should be employed to avoid severe constipation as good
hydration, food additives, stool softeners, and laxatives.
For patients with adult onset type who have psychiatric
manifestations, conventional antipsychotic or antidepressant
therapy may be used, but the clinical response is unpredictable
and generally poor.
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Part II: Choose one correct answer for the following questions
1. The basis for the treatment of phenylketonuria is:A. Inhibition of enzymes that convert phenylalanine to
toxic by-products
B. Rapid excretion of toxic by-products of
phenylalanine
C. Restriction of dietary intake of phenyalanine
D. Stimulation of alternative pathways of phenylalanine
metabolism
2. The basis for the current treatment of urea cycle disor-
ders is:
A. Replacement of missing enzyme activity by enzyme
infusion
B. Providing alternative pathways for excretion of
ammonia
C. Coenzyme replacement
D. Kidney transplant
3. Which of the following inborn errors of metabolism can
be treated by enzyme infusion?A. Galactosemia
B. Dihydropteridine reductase deﬁciency
C. Canavan disease
D. Gaucher disease
4. The one factor known to be associated with nondisjunc-
tion is:A. Radiation exposure
B. Alcohol exposure
C. Advanced maternal age
D. Advanced paternal age
5. The translocation of chromosomes 9 and 22 is character-
istic of:
A. Retinoblastoma
B. Li-Fraumeni syndrome
C. Chronic myelogenous leukemia
D. Soft tissue sarcoma
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done by:
A. Enzyme assay
B. DNA-testing
C. Analysis of a blood smear
D. Ophthalmological testing looking for a cherry-red
spot
7. Which of the following is used as the mainstay of treat-
ment of hemochromatosis?
A. Transfusion
B. Chelation
C. Phlebotomy
D. Iron
8. Which of the following is the usual treatment of hemo-
philia A?
A. Blood transfusion
B. Liver transplant
C. Bone marrow transplant
D. Infusion of factor VIII as needed
9. The odor of sweaty feet is classically described in:A. Phenylketonuria
B. Maple syrup urine disease
C. Methylmalonic acidemia
D. Isovaleric academia
10. Rubinstein Taybi syndrome is due to:
A. Deletion of chromosome 8q
B. Deletion of chromosome16p
C. Deletion of chromosome 17p
D. Deletion of chromosome22q
11. The karyotype: 47,XX,+13 designates which of the
following:A. A female with trisomy 13
B. A female with 13 extra chromosomes
C. A female with an enlarged copy of chromosome 13
D. A female with extra material on chromosomes 13
12. Uniparental disomy for chromosome 15 in which both
chromosomes are maternally derived is associated with
which of the following syndromes?A. Prader-Willi syndrome
B. Angelman syndrome
C. Rett syndrome
D. Beckwith-Wiedemann syndrome
13. Two parents with autosomal recessive albinism have a
child who does not have albinism. This is best explained
by:
A. An incorrect diagnosis in one parent
B. Misattributed paternity
C. Genetic heterogeneity
D. Reversion of one of the mutant alleles to wild type
14. In which of the following chromosome disorders is the
extra chromosome contributed in nearly equal propor-
tions by the mother and the father?A. 47, XXY
B. Trisomy 21
C. Trisomy 18
D. 47, XYY
15. Complications observed in patient with propionic acide-
mia and methylmalonic acidemia include all of the fol-
lowing except:A. cardiomyopathy
B. cataracts
C. renal failure
D. pancreatitis
Answers to MCQs:
1 C 6 A 11 A
2 B 7 C 12 A
3 D 8 D 13 C
4 C 9 D 14 A
5 C 10 B 15 B
